A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS

Not Applicable

Completed

• Conditions: Meningitis, Cryptococcal; HIV Infections

• Registration Number: NCT00002294
• Lead Sponsor: Pfizer

Brief Summary

To compare the safety and effectiveness of fluconazole with that of placebo as maintenance treatment for preventing the relapse of cryptococcal meningitis in patients with AIDS.

Detailed Description

Not available

Study Timeline

• Status Verified: 1989-12
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (5)

UCI Med Ctr; 🇺🇸 Orange, California, United States

Dr Robert Larsen; 🇺🇸 Los Angeles, California, United States

UCSD; 🇺🇸 San Diego, California, United States

Stanford Univ School of Medicine; 🇺🇸 Stanford, California, United States

Dr Paul Rothman; 🇺🇸 Sherman Oaks, California, United States